甲基黄嘌呤用于预防或治疗晚期早产儿间歇性低氧血症或呼吸功能不全。

IF 8.8 2区医学 Q1 MEDICINE, GENERAL & INTERNAL

Cochrane Database of Systematic Reviews Pub Date : 2024-11-20 DOI:10.1002/14651858.CD016113

Enrico Bodrero, María Carolina Isaza-López, Adrienne Pahl, Michelle Fiander, Roger Soll, Matteo Bruschettini

引用次数: 0

摘要

目标：这是一份科克伦综述（干预）协议。目标如下：评估甲基黄嘌呤类药物在预防或治疗晚期早产儿间歇性低氧血症或呼吸功能不全方面的利弊。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Methylxanthines for the prevention or treatment of intermittent hypoxemia or respiratory insufficiency in late preterm infants.

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the benefits and harms of methylxanthines in preventing or treating intermittent hypoxemia or respiratory insufficiency in late preterm infants.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Cochrane Database of Systematic Reviews 医学-医学：内科

CiteScore

10.60

自引率

2.40%

发文量

173

审稿时长

1-2 weeks

期刊介绍： The Cochrane Database of Systematic Reviews (CDSR) stands as the premier database for systematic reviews in healthcare. It comprises Cochrane Reviews, along with protocols for these reviews, editorials, and supplements. Owned and operated by Cochrane, a worldwide independent network of healthcare stakeholders, the CDSR (ISSN 1469-493X) encompasses a broad spectrum of health-related topics, including health services.